Description

Remdesivir

Remdesivir is a high-purity, antiviral nucleotide analog used in pharmaceutical formulations for the treatment of viral infections, including RNA viruses. It functions as a prodrug that inhibits viral RNA-dependent RNA polymerase, preventing viral replication and reducing viral load. Remdesivir is widely used in intravenous formulations for hospitalized patients with acute viral infections. Remdesivir
• Is an antiviral nucleotide analog for pharmaceutical use
• Is used in intravenous solutions for treatment of RNA viral infections
• Inhibits viral RNA polymerase to suppress replication
• Is suitable for acute treatment in hospitalized and critical care patients
• Is manufactured under Good Manufacturing Practice (GMP) certified conditions
• Is supplied with complete regulatory documentation including Certificate of Analysis (CoA) and technical data
Remdesivir is chemically designated as 2-Ethylbutyl (2S)-2-[[[(1R,2S,3S,4R)-2-ethyl-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-1-yl]methoxy-phenoxyphosphoryl]amino]propanoate. It appears as a white to off-white crystalline powder with limited solubility in water, formulated into sterile IV solutions for clinical use.
In pharmaceutical applications, Remdesivir is used in:
• Intravenous formulations for treatment of RNA viral infections
• Hospitalized patient therapy to reduce viral replication and improve recovery
• Clinical research and emergency use antiviral studies
• Combination antiviral therapies for synergistic effects in severe infections
• Compounded parenteral solutions under controlled hospital or clinical settings
Remdesivir acts as a chain-terminating inhibitor of viral RNA polymerase, thereby blocking viral genome replication. Its prodrug design improves cellular uptake and intracellular conversion to the active triphosphate metabolite.
CarboMer supplies Remdesivir with control over assay, polymorphic form, residual solvents, and microbial purity. The material is suitable for sterile parenteral formulation and regulated pharmaceutical applications.
The material is packaged in sealed, moisture-resistant, tamper-evident containers. Available in research, pilot, and commercial-scale quantities. Minimum order quantities (MOQ), lead times, and documentation including CoA and SDS are provided upon request.
Each batch is tested for identity (IR, HPLC), assay, residual solvents, water content, heavy metals, and microbial limits. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and full traceability documentation accompany every shipment.
As with all CarboMer antiviral APIs, Remdesivir is supported by formulation guidance, regulatory expertise, and reliable global supply to ensure safe, effective, and compliant pharmaceutical products.